144 related articles for article (PubMed ID: 29427628)
1. Protection of therapeutic antibodies from visible light induced degradation: Use safe light in manufacturing and storage.
Du C; Barnett G; Borwankar A; Lewandowski A; Singh N; Ghose S; Borys M; Li ZJ
Eur J Pharm Biopharm; 2018 Jun; 127():37-43. PubMed ID: 29427628
[TBL] [Abstract][Full Text] [Related]
2. Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of
Prajapati I; Larson NR; Choudhary S; Kalonia C; Hudak S; Esfandiary R; Middaugh CR; Schöneich C
Mol Pharm; 2021 Sep; 18(9):3223-3234. PubMed ID: 34482697
[TBL] [Abstract][Full Text] [Related]
3. Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.
Dion MZ; Leiske D; Sharma VK; Zuch de Zafra CL; Salisbury CM
Pharm Res; 2018 Oct; 35(11):222. PubMed ID: 30280329
[TBL] [Abstract][Full Text] [Related]
4. Photoinduced cross-linking of formulation buffer amino acids to monoclonal antibodies.
Powell T; Knight MJ; Wood A; O'Hara J; Burkitt W
Eur J Pharm Biopharm; 2021 Mar; 160():35-41. PubMed ID: 33508437
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B
Du C; Martin R; Huang Y; Borwankar A; Tan Z; West J; Singh N; Borys M; Ghose S; Ludwig R; Tao L; Li ZJ
Biotechnol Bioeng; 2018 Apr; 115(4):900-909. PubMed ID: 29205285
[TBL] [Abstract][Full Text] [Related]
6. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.
Schöneich C
Pharm Res; 2020 Feb; 37(3):45. PubMed ID: 32016661
[TBL] [Abstract][Full Text] [Related]
7. Effect of photo-degradation on the structure, stability, aggregation, and function of an IgG1 monoclonal antibody.
Shah DD; Zhang J; Maity H; Mallela KMG
Int J Pharm; 2018 Aug; 547(1-2):438-449. PubMed ID: 29883793
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the degradation products of a color-changed monoclonal antibody: tryptophan-derived chromophores.
Li Y; Polozova A; Gruia F; Feng J
Anal Chem; 2014 Jul; 86(14):6850-7. PubMed ID: 24937252
[TBL] [Abstract][Full Text] [Related]
9. Characterization of N-Acetyl-Tryptophan Degradation in Protein Therapeutic Formulations.
Hogan KL; Leiske D; Salisbury CM
J Pharm Sci; 2017 Dec; 106(12):3499-3506. PubMed ID: 28844684
[TBL] [Abstract][Full Text] [Related]
10. Photosensitizers form in histidine buffer and mediate the photodegradation of a monoclonal antibody.
Stroop SD; Conca DM; Lundgard RP; Renz ME; Peabody LM; Leigh SD
J Pharm Sci; 2011 Dec; 100(12):5142-55. PubMed ID: 21786276
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a Degradant in a Biologics Formulation Buffer Containing L-Histidine.
Wang C; Yamniuk A; Dai J; Chen S; Stetsko P; Ditto N; Zhang Y
Pharm Res; 2015 Aug; 32(8):2625-35. PubMed ID: 25670525
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Methionine Oxidation of a Pharmaceutical Antibody Stored in a Polymer-Based Syringe.
Masato A; Kiichi F; Uchiyama S
J Pharm Sci; 2016 Feb; 105(2):623-629. PubMed ID: 26462145
[TBL] [Abstract][Full Text] [Related]
13. Protect from light: photodegradation and protein biologics.
Kerwin BA; Remmele RL
J Pharm Sci; 2007 Jun; 96(6):1468-79. PubMed ID: 17230445
[TBL] [Abstract][Full Text] [Related]
14. Chemical and physical instabilities in manufacturing and storage of therapeutic proteins.
Krause ME; Sahin E
Curr Opin Biotechnol; 2019 Dec; 60():159-167. PubMed ID: 30861476
[TBL] [Abstract][Full Text] [Related]
15. Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule.
Folzer E; Diepold K; Bomans K; Finkler C; Schmidt R; Bulau P; Huwyler J; Mahler HC; Koulov AV
J Pharm Sci; 2015 Sep; 104(9):2824-31. PubMed ID: 26010344
[TBL] [Abstract][Full Text] [Related]
16. Stress Temperature Studies in Small Scale Hastelloy® Drug Substance Containers Lead to Increased Extent of and Increased Variability in Antibody-Drug Conjugate and Monoclonal Antibody Aggregation: Evidence for Novel Oxidation-Induced Crosslinking in Monoclonal Antibodies.
Klair N; Kim MT; Lee A; Xiao NJ; Patel AR
J Pharm Sci; 2021 Apr; 110(4):1615-1624. PubMed ID: 33035540
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Antibody Aggregation Associated with Free Radical Induced Oxidation.
Zheng K; Ren D; Wang YJ; Lilyestrom W; Scherer T; Hong JKY; Ji JA
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921206
[TBL] [Abstract][Full Text] [Related]
18. Effect of ambient light on IgG1 monoclonal antibodies during drug product processing and development.
Sreedhara A; Yin J; Joyce M; Lau K; Wecksler AT; Deperalta G; Yi L; John Wang Y; Kabakoff B; Kishore RS
Eur J Pharm Biopharm; 2016 Mar; 100():38-46. PubMed ID: 26707077
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions.
Grassi L; Cabrele C
Amino Acids; 2019 Nov; 51(10-12):1409-1431. PubMed ID: 31576455
[TBL] [Abstract][Full Text] [Related]
20. Formulation and manufacturability of biologics.
Shire SJ
Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
